IL17A and Miyoshi myopathy: Research conducted in MM cell models shows that IL-17–producing T cells induce osteoclast activation and that IL-17 production directly correlates with lytic bone disease, irrespective of the tumor burden, indicating that the Th17 T-cell phenotype is a key predictor of lytic bone disease in MM [54].